As Global Fund Board Meets To Choose New Director, Sands Seeks To Reinstate Candidacy 13/11/2017 William New Days after withdrawing from consideration to be the next director of the Global Fund for AIDS, Tuberculosis and Malaria, the UK's Peter Sands has asked to be reinstated. The actions come as the Fund's Board gathers this week to choose among the final candidates for head of the international health funding organisation based in Geneva. Continue reading -> Global Fund For AIDS, TB & Malaria Narrows Director Candidates To Four 23/10/2017 William New The Global Fund for AIDS, Tuberculosis and Malaria announced today it has narrowed the search to four high-level candidates, coming from backgrounds in banking, development agencies and United Nations programs. Continue reading -> World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Canadian Universities Not Contributing Enough To Neglected Health Needs, UAEM Report Says 03/10/2017 Catherine Saez The Universities Allied for Essential medicines (UAEM) evaluated 15 Canadian research-intensive universities on their contributions to biomedical research on neglected health needs, access to medicines, and education concerning access and innovation issues. The results show that for a number of those universities, this contribution is sub-optimal. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 Catherine Saez Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading -> Posts navigation Older postsNewer posts
Global Fund For AIDS, TB & Malaria Narrows Director Candidates To Four 23/10/2017 William New The Global Fund for AIDS, Tuberculosis and Malaria announced today it has narrowed the search to four high-level candidates, coming from backgrounds in banking, development agencies and United Nations programs. Continue reading -> World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Canadian Universities Not Contributing Enough To Neglected Health Needs, UAEM Report Says 03/10/2017 Catherine Saez The Universities Allied for Essential medicines (UAEM) evaluated 15 Canadian research-intensive universities on their contributions to biomedical research on neglected health needs, access to medicines, and education concerning access and innovation issues. The results show that for a number of those universities, this contribution is sub-optimal. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 Catherine Saez Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading -> Posts navigation Older postsNewer posts
World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Canadian Universities Not Contributing Enough To Neglected Health Needs, UAEM Report Says 03/10/2017 Catherine Saez The Universities Allied for Essential medicines (UAEM) evaluated 15 Canadian research-intensive universities on their contributions to biomedical research on neglected health needs, access to medicines, and education concerning access and innovation issues. The results show that for a number of those universities, this contribution is sub-optimal. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 Catherine Saez Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading -> Posts navigation Older postsNewer posts
WHO Official On Antimicrobial Resistance: Poor Quality Medicines Entering At “Last Mile” To Patient 05/10/2017 William New At a recent event on the margin of the United Nations General Assembly, a senior World Health Organization official gave an update on global efforts against substandard and falsified medicines in the context of the fight against antimicrobial resistance (AMR). And a key issue is that often after arriving safely in the capitals, something happens just before quality-assured medicines reach the patient, contributing to AMR. Continue reading -> Canadian Universities Not Contributing Enough To Neglected Health Needs, UAEM Report Says 03/10/2017 Catherine Saez The Universities Allied for Essential medicines (UAEM) evaluated 15 Canadian research-intensive universities on their contributions to biomedical research on neglected health needs, access to medicines, and education concerning access and innovation issues. The results show that for a number of those universities, this contribution is sub-optimal. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 Catherine Saez Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading -> Posts navigation Older postsNewer posts
Canadian Universities Not Contributing Enough To Neglected Health Needs, UAEM Report Says 03/10/2017 Catherine Saez The Universities Allied for Essential medicines (UAEM) evaluated 15 Canadian research-intensive universities on their contributions to biomedical research on neglected health needs, access to medicines, and education concerning access and innovation issues. The results show that for a number of those universities, this contribution is sub-optimal. Continue reading -> Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 Catherine Saez Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading -> Posts navigation Older postsNewer posts
Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest 25/09/2017 William New NEW YORK -- In the midst of the high-level meetings of the annual United Nations General Assembly last week, health officials from the UN and foundations announced what they called a breakthrough pricing agreement that will speed the availability of "the first affordable, generic, single-pill HIV treatment regimen containing [the key compound] dolutegravir to public sector purchasers in low- and middle-income countries at around $75 per person, per year." A senior official at Unitaid, the drug purchasing mechanism that helped reach the deal, explained to Intellectual Property Watch how it came about and why this is significant. Continue reading -> WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 Catherine Saez Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading -> Posts navigation Older postsNewer posts
WHO Issues Alarming Report On Coming Shortage Of Antibiotics 20/09/2017 William New A new report issued today by the World Health Organization shows a “serious lack” of new antibiotics in development, even as resistance to existing antibiotics are on the rise. The head of the WHO said the report shows an “urgent need” for investment into research and development. In addition, a second report today from WHO […] Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 Catherine Saez Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading -> Posts navigation Older postsNewer posts
Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 Catherine Saez Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading -> Posts navigation Older postsNewer posts
The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 Catherine Saez Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading -> Posts navigation Older postsNewer posts
Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 Catherine Saez Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading -> Posts navigation Older postsNewer posts